245 related articles for article (PubMed ID: 35216001)
1. THαβ Immunological Pathway as Protective Immune Response against Prion Diseases: An Insight for Prion Infection Therapy.
Tsou A; Chen PJ; Tsai KW; Hu WC; Lu KC
Viruses; 2022 Feb; 14(2):. PubMed ID: 35216001
[TBL] [Abstract][Full Text] [Related]
2. Type I interferon protects neurons from prions in in vivo models.
Ishibashi D; Homma T; Nakagaki T; Fuse T; Sano K; Satoh K; Mori T; Atarashi R; Nishida N
Brain; 2019 Apr; 142(4):1035-1050. PubMed ID: 30753318
[TBL] [Abstract][Full Text] [Related]
3. Absence of CD14 delays progression of prion diseases accompanied by increased microglial activation.
Sakai K; Hasebe R; Takahashi Y; Song CH; Suzuki A; Yamasaki T; Horiuchi M
J Virol; 2013 Dec; 87(24):13433-45. PubMed ID: 24089559
[TBL] [Abstract][Full Text] [Related]
4. A neuroprotective role for microglia in prion diseases.
Zhu C; Herrmann US; Falsig J; Abakumova I; Nuvolone M; Schwarz P; Frauenknecht K; Rushing EJ; Aguzzi A
J Exp Med; 2016 May; 213(6):1047-59. PubMed ID: 27185853
[TBL] [Abstract][Full Text] [Related]
5. [Protective Role of the Host Innate Immune System in Prion Pathogenesis].
Ishibashi D
Yakugaku Zasshi; 2019; 139(7):993-998. PubMed ID: 31257258
[TBL] [Abstract][Full Text] [Related]
6. Complement 3
Hartmann K; Sepulveda-Falla D; Rose IVL; Madore C; Muth C; Matschke J; Butovsky O; Liddelow S; Glatzel M; Krasemann S
Acta Neuropathol Commun; 2019 May; 7(1):83. PubMed ID: 31118110
[TBL] [Abstract][Full Text] [Related]
7. Antibody-mediated inhibition of integrin α5β1 blocks neurotoxic prion peptide PrP106-126-induced activation of BV2 microglia.
Chang J; Yang L; Kouadir M; Peng Y; Zhang S; Shi F; Zhou X; Yin X; Zhao D
J Mol Neurosci; 2012 Sep; 48(1):248-52. PubMed ID: 22648512
[TBL] [Abstract][Full Text] [Related]
8. Microglia in prion diseases.
Aguzzi A; Zhu C
J Clin Invest; 2017 Sep; 127(9):3230-3239. PubMed ID: 28714865
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA 146a (miR-146a) is over-expressed during prion disease and modulates the innate immune response and the microglial activation state.
Saba R; Gushue S; Huzarewich RL; Manguiat K; Medina S; Robertson C; Booth SA
PLoS One; 2012; 7(2):e30832. PubMed ID: 22363497
[TBL] [Abstract][Full Text] [Related]
10. Accelerated prion disease in the absence of interleukin-10.
Thackray AM; McKenzie AN; Klein MA; Lauder A; Bujdoso R
J Virol; 2004 Dec; 78(24):13697-707. PubMed ID: 15564479
[TBL] [Abstract][Full Text] [Related]
11. RNA-seq and network analysis reveal unique glial gene expression signatures during prion infection.
Carroll JA; Race B; Williams K; Striebel J; Chesebro B
Mol Brain; 2020 May; 13(1):71. PubMed ID: 32381108
[TBL] [Abstract][Full Text] [Related]
12. Adult human microglia secrete cytokines when exposed to neurotoxic prion protein peptide: no intermediary role for prostaglandin E2.
Veerhuis R; Hoozemans JJ; Janssen I; Boshuizen RS; Langeveld JP; Eikelenboom P
Brain Res; 2002 Jan; 925(2):195-203. PubMed ID: 11792368
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory response of microglia to prions is controlled by sialylation of PrP
Srivastava S; Katorcha E; Makarava N; Barrett JP; Loane DJ; Baskakov IV
Sci Rep; 2018 Jul; 8(1):11326. PubMed ID: 30054538
[TBL] [Abstract][Full Text] [Related]
14. Lymph nodal prion replication and neuroinvasion in mice devoid of follicular dendritic cells.
Prinz M; Montrasio F; Klein MA; Schwarz P; Priller J; Odermatt B; Pfeffer K; Aguzzi A
Proc Natl Acad Sci U S A; 2002 Jan; 99(2):919-24. PubMed ID: 11792852
[TBL] [Abstract][Full Text] [Related]
15. Effect of Microglial Inflammation in Prion Disease.
Ano Y; Sakudo A; Onodera T
Curr Issues Mol Biol; 2020; 36():1-12. PubMed ID: 31486773
[TBL] [Abstract][Full Text] [Related]
16. Microglia in Prion Diseases: Angels or Demons?
Peggion C; Stella R; Lorenzon P; Spisni E; Bertoli A; Massimino ML
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092220
[TBL] [Abstract][Full Text] [Related]
17. Prion disease pathogenesis in the absence of the commensal microbiota.
Bradford BM; Tetlow L; Mabbott NA
J Gen Virol; 2017 Jul; 98(7):1943-1952. PubMed ID: 28708055
[TBL] [Abstract][Full Text] [Related]
18. Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins.
Asante EA; Gowland I; Grimshaw A; Linehan JM; Smidak M; Houghton R; Osiguwa O; Tomlinson A; Joiner S; Brandner S; Wadsworth JDF; Collinge J
J Gen Virol; 2009 Mar; 90(Pt 3):546-558. PubMed ID: 19218199
[TBL] [Abstract][Full Text] [Related]
19. Absence of detectable IL-1beta production in murine prion disease: a model of chronic neurodegeneration.
Walsh DT; Betmouni S; Perry VH
J Neuropathol Exp Neurol; 2001 Feb; 60(2):173-82. PubMed ID: 11273005
[TBL] [Abstract][Full Text] [Related]
20. Flow Cytometric Detection of PrP
Yamasaki T; Suzuki A; Hasebe R; Horiuchi M
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
